Achieve Life Sciences, Inc. (ACHV)
7.84
-0.65
(-7.66%)
USD |
NASDAQ |
Sep 08, 16:00
7.90
+0.06
(+0.77%)
Pre-Market: 08:37
Achieve Life Sciences Total Assets (Quarterly) : 190.44M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 190.44M |
| March 31, 2026 | 33.10M |
| December 31, 2025 | 42.07M |
| September 30, 2025 | 52.04M |
| June 30, 2025 | 58.94M |
| March 31, 2025 | 27.36M |
| December 31, 2024 | 38.63M |
| September 30, 2024 | 47.92M |
| June 30, 2024 | 64.79M |
| March 31, 2024 | 70.03M |
| December 31, 2023 | 19.37M |
| September 30, 2023 | 24.34M |
| June 30, 2023 | 28.92M |
| March 31, 2023 | 20.80M |
| December 31, 2022 | 29.97M |
| September 30, 2022 | 23.72M |
| June 30, 2022 | 33.98M |
| March 31, 2022 | 40.61M |
| December 31, 2021 | 47.52M |
| September 30, 2021 | 37.80M |
| June 30, 2021 | 45.56M |
| March 31, 2021 | 33.66M |
| December 31, 2020 | 40.30M |
| September 30, 2020 | 27.62M |
| June 30, 2020 | 16.46M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.65M |
| December 31, 2019 | 21.08M |
| September 30, 2019 | 11.49M |
| June 30, 2019 | 14.76M |
| March 31, 2019 | 14.50M |
| December 31, 2018 | 19.08M |
| September 30, 2018 | 17.14M |
| June 30, 2018 | 19.22M |
| March 31, 2018 | 8.46M |
| December 31, 2017 | 9.892M |
| September 30, 2017 | 13.03M |
| June 30, 2017 | 14.88M |
| March 31, 2017 | 17.90M |
| December 31, 2016 | 27.47M |
| September 30, 2016 | 35.07M |
| June 30, 2016 | 42.20M |
| March 31, 2016 | 48.84M |
| December 31, 2015 | 58.21M |
| September 30, 2015 | 68.24M |
| June 30, 2015 | 63.36M |
| March 31, 2015 | 46.38M |
| December 31, 2014 | 56.29M |
| September 30, 2014 | 62.65M |
| June 30, 2014 | 49.73M |
| March 31, 2014 | 49.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 183.47M |
| Perspective Therapeutics, Inc. | 392.02M |
| MiMedx Group, Inc. | 281.00M |
| ProText Mobility, Inc. | 611.30M |
| ABVC BioPharma, Inc. | 19.40M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 205.12M |
| Shareholders Equity (Quarterly) | -14.68M |
| Debt to Equity Ratio | -1.018 |
| Current Ratio | 0.9526 |
| Net Debt Paydown Yield | -0.15% |